...
首页> 外文期刊>The Lancet >Interventional management of resistant hypertension.
【24h】

Interventional management of resistant hypertension.

机译:耐药性高血压的介入治疗。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

In the late 1940s, subdiaphragmatic splanchnicectomy was used for the treatment of severe hypertension. Surgical sympathectomy was effective but carried a high price: prolonged hospitalisation, postural hypotension, syncope, impotence, and even difficulty in walking. However, this approach was justified at that time, in view of the lack of antihypertensive drugs and the poor outcome of malignant hypertension. The many effective drugs we have nowadays make an interventional therapeutic approach for hypertension strange and unattractive. The control of hypertension, however, remains disappointingly low, leaving uncontrolled patients at increased cardiovascular risk. Thus the need for new therapeutic strategies to address this problem permits the use of interventional techniques. A device that activates carotid baroreceptors is currently in phase III studies in resistant hypertension.
机译:在1940年代后期,dia下内脏切除术被用于治疗严重的高血压。手术交感神经切除术是有效的,但代价高昂:长期住院,体位性低血压,晕厥,阳imp甚至行走困难。但是,鉴于缺乏降压药和恶性高血压的不良结果,这种方法在当时是合理的。如今,我们拥有的许多有效药物使高血压的介入治疗方法变得陌生且缺乏吸引力。然而,高血压的控制率仍然令人失望地低,使不受控制的患者罹患心血管疾病的风险增加。因此,对于解决该问题的新治疗策略的需求允许使用介入技术。目前,在抗药性高血压的III期研究中,激活颈动脉压力感受器的装置。

著录项

  • 来源
    《The Lancet》 |2009年第9671期|共3页
  • 作者

    Doumas M; Douma S;

  • 作者单位
  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号